HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of six rounds of mass drug administration on Brugian filariasis and soil-transmitted helminth infections in eastern Indonesia.

AbstractBACKGROUND:
The lymphatic filarial parasite Brugia timori occurs only in eastern Indonesia where it causes high morbidity. The absence of an animal reservoir, the inefficient transmission by Anopheles mosquitoes and the high sensitivity to DEC/albendazole treatment make this species a prime candidate for elimination by mass drug administration (MDA).
METHODOLOGY/PRINCIPAL FINDINGS:
We evaluated the effect of MDA using DEC and albendazole on B. timori and soil transmitted helminths (STH) in a cross-sectional study of a sentinel village on Alor Island annually over a period of 10 years. Pre-MDA the microfilaria (MF) prevalence was 26% and 80% of the residents had filaria-specific IgG4 antibodies. In 2010, 34 months after the 6(th) round of MDA, MF and antibody rates were only 0.17% and 6.4%, respectively. The MDA campaign had also a beneficial effect on STH. Baseline prevalence rates for Ascaris, hookworm and Trichuris were 34%, 28%, and 11%, respectively; these rates were reduced to 27%, 4%, and 2% one year after the 5(th) round of MDA. Unfortunately, STH rates rebounded 34 months after cessation of MDA and approached pre-MDA rates. However, the intensity of STH infection in 2009 was still reduced, and no heavy infections were detected.
CONCLUSIONS/SIGNIFICANCE:
MDA with DEC/albendazole has had a major impact on B. timori MF and IgG4 antibody rates, providing a proof of principle that elimination is feasible. We also documented the value of annual DEC/albendazole as a mass de-worming intervention and the importance of continuing some form of STH control after cessation of MDA for filariasis.
AuthorsTaniawati Supali, Yenny Djuardi, Mark Bradley, Rahmah Noordin, Paul Rückert, Peter U Fischer
JournalPLoS neglected tropical diseases (PLoS Negl Trop Dis) Vol. 7 Issue 12 Pg. e2586 ( 2013) ISSN: 1935-2735 [Electronic] United States
PMID24349595 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anthelmintics
  • Antibodies, Helminth
  • Immunoglobulin G
  • Albendazole
  • Diethylcarbamazine
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Albendazole (administration & dosage)
  • Animals
  • Anthelmintics (administration & dosage)
  • Antibodies, Helminth (blood)
  • Brugia (isolation & purification)
  • Child
  • Child, Preschool
  • Diethylcarbamazine (administration & dosage)
  • Drug Therapy (methods)
  • Female
  • Filariasis (drug therapy, epidemiology)
  • Helminthiasis (drug therapy, epidemiology)
  • Humans
  • Immunoglobulin G (blood)
  • Indonesia (epidemiology)
  • Intestinal Diseases (drug therapy, epidemiology)
  • Intestinal Diseases, Parasitic
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: